Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China · Delayed Price · Currency is CNY 62.70
+0.35 (0.56%)
Apr 9, 2026, 1:10 PM CST
SHA:688799 Revenue
In the year 2025, Hunan Warrant Pharmaceutical Co.,Ltd had annual revenue of 1.52B CNY with 7.26% growth. Hunan Warrant Pharmaceutical Co.,Ltd had revenue of 429.77M in the quarter ending December 31, 2025, with 25.06% growth.
Revenue
1.52B
Revenue Growth
+7.26%
P/S Ratio
5.40
Revenue / Employee
n/a
Employees
1,234
Market Cap
8.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | 102.65M | 7.26% |
| Dec 31, 2024 | 1.41B | -19.84M | -1.38% |
| Dec 31, 2023 | 1.43B | 140.13M | 10.84% |
| Dec 31, 2022 | 1.29B | 146.06M | 12.74% |
| Dec 31, 2021 | 1.15B | 195.97M | 20.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 2.23B |
| Guangxi Wuzhou Zhongheng Group | 1.75B |